Pediatrix Medical Group (NYSE:MD) Stock Price Expected to Rise, UBS Group Analyst Says
Pediatrix Medical Group (NYSE:MD – Get Free Report) had its price objective raised by research analysts at UBS Group from $16.50 to $18.50 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s price target would suggest a potential upside of 18.83% from […]
Pediatrix Medical Group (NYSE:MD – Get Free Report) had its price objective raised by research analysts at UBS Group from $16.50 to $18.50 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s price target would suggest a potential upside of 18.83% from […]
